- Healthcare 150
- Posts
- Why Hospital M&A Is Concentrating in U.S. Cities
Why Hospital M&A Is Concentrating in U.S. Cities
Urban concentration, cost pressures, and digital care deals signal a new phase in hospital strategy.
Good morning, ! Today we explore how hospital M&A activity in the United States is increasingly concentrated in urban and metropolitan areas. Meanwhile, total drug spending continues to rise, and pediatric telehealth provider My Pediatric Doctor secures growth capital from QC Capital Group to support its expansion.
Want to advertise in Healthcare 150? Check out our ad platform, here.
Know someone in the healthcare space who should see this? Forward it their way. Here’s the link.
— The Healthcare150 Team
HEADLINE OF THE WEEK
Drug Spending Reaccelerates
U.S. drug spending is quietly entering another expansion cycle. Net pharmaceutical spend climbed from $343B in 2019 to $487B in 2024, a $144B increase in five years. Growth accelerated after 2020, with the market adding $93B between 2021 and 2024 alone, signaling renewed momentum after the pandemic-era slowdown.
The key shift is mix. Growth is increasingly concentrated in high cost specialty therapies including oncology, immunology, and next generation biologics. These categories carry higher price points and longer treatment durations, which means incremental innovation translates directly into higher system spend.
For investors and operators, the implication is structural. Even as policymakers intensify scrutiny on drug pricing, the underlying demand curve is moving upward. Aging populations, broader biologic adoption, and expanded indications continue to expand the addressable market faster than pricing reforms can compress it.
The takeaway is straightforward. Pharmaceutical spending is not stabilizing. It is compounding, and the next battleground will center on who captures the value created by increasingly expensive therapies. (More)
PRESENTED BY JUNIPER SQUARE
The private markets have evolved beyond traditional closed-end funds. More GPs are launching new fund structures tailored to different investor profiles with different liquidity expectations and faster operating cadences.
That shift changes what “good operations” looks like. Investor onboarding, servicing, reporting, and communications cannot be treated as a series of handoffs across point solutions, as disconnection creates friction, inconsistency, and slower decision-making.
With all these new fund structures in play, the operating model decides who scales and who stalls. Connected fund and investor data turns execution into a competitive advantage — giving teams the speed, precision, and confidence to scale without adding friction.
Download the report to understand what’s driving the rise of new fund structures and the operational implications for GPs.
Supporting our sponsors supports our free newsletters. Please support our sponsors!
MICROSURVEY
How is healthcare M&A strategy adapting in the current environment? |
DEAL OF THE WEEK
QC Capital Backs Pediatric Telehealth Platform
QC Capital Group announced a strategic investment in My Pediatric Doctor, a 24/7 urgent care pediatric telehealth platform designed to provide on-demand care for children across all 50 U.S. states, Puerto Rico, and Guam.
Led by CEO Eric Doherty, the company plans to use the funding to scale its nationwide platform, giving families direct access to board-certified pediatric providers for non-emergency conditions, follow-ups, and urgent consultations from home.
Why it matters: Pediatric ER visits are often driven by access and timing constraints, not medical severity. Platforms like My Pediatric Doctor aim to redirect acute but non-critical pediatric cases to virtual care, easing pressure on emergency departments while improving convenience for families.
For investors, the thesis is straightforward: telehealth is evolving into core healthcare infrastructure, particularly in high-demand, access-constrained specialties like pediatrics. (More)
REGIONAL FOCUS
Hospital Consolidation Is an Urban Story
Hospital M&A in the U.S. is overwhelmingly concentrated in metropolitan markets. While 60.2% of all short term acute care hospitals are located in urban areas, those markets account for nearly all recent ownership changes. Among acquiring systems, 88.1% are urban based. Among hospitals being purchased, 87.3% are also urban. Rural participation is limited to just 11.9% of buyers and 12.7% of acquired facilities.
The disparity highlights where consolidation economics actually work. Urban markets offer higher patient density, stronger commercial payer mix, and the scale needed to support modern capital requirements including IT infrastructure, specialty services, and physician networks. Rural hospitals, by contrast, often lack the financial stability to act as acquirers and instead face closures, affiliations, or government support.
For operators and investors, the signal is structural. Consolidation is not evenly distributed across U.S. healthcare geography. Capital continues to flow toward dense urban systems where integration creates measurable operating leverage.
The result is a widening structural gap. Urban systems are scaling through acquisitions, while rural hospitals remain on the defensive. (More)
"It is no measure of health to be well adjusted to a profoundly sick society."
Jiddu Krishnamurti